Astellas Pharma Global Development is the research and development arm of Tokyo-based Astellas Pharma Inc., the second-largest Japan-based pharmaceutical company. At Astellas, our commitment to R&D is based on the development of first-in-class and best-in-class products in our therapeutic areas of focus. In the U.S., our robust pipeline is centered on the therapeutic areas of oncology, urology, cardiology, infectious disease, organ transplantation, neuroscience and dermatology. In the area of oncology, Astellas subsidiary Agensys, Inc of Santa Monica, California is developing a promising pipeline of therapeutic fully human monoclonal antibodies to treat solid tumor cancers. Astellas is proud of its commitment to changing tomorrow by discovering and developing innovative therapies that address unmet medical needs. All global development programs are run out of the Astellas headquarters for the Americas located in Deerfield, Illinois. For more information about our global research and development activities, please visit our Web site.
PMC Membership
Members of PMC participate on our committees, attend our events, generate networking and business development opportunities, and, most importantly, contribute to a unique organization that is positioned to ensure that public opinion and policy are aligned with personalized medicine’s new emerging scientific paradigms. Members also learn about the latest developments in science, policy and business through forums, an e-newsletter member update sent every two weeks, and a newsletter.
PMC membership encompasses a broad spectrum of academic, industrial, patient and health care provider constituencies. Membership is open, but not limited, to universities and academic medical centers, non-profit research entities, relevant trade associations, patient advocacy groups, government officials (ex-officio), health care organizations, health care providers, payers, information technology companies and research-based commercial companies that offer an array of products and services including research tools, diagnostic technologies and products, screening services and therapeutic interventions.
Featured Member
Ready to Join?
PMC Members shape and advance the future of personalized medicine.
PMC Newsletter
Current Issue >>
Subscribe to PMC Newsletter
ShareThis